Status:
UNKNOWN
Danish Study of Non-Invasive Diagnostic Testing in Coronary Artery Disease 3
Lead Sponsor:
University of Aarhus
Conditions:
Angina Pectoris
Atherosclerosis
Eligibility:
All Genders
30-100 years
Brief Summary
In a cohort of symptomatic patients referred to coronary computed tomography angiography (CCTA), the investigators aim is: 1. To investigate and compare the diagnostic precision of Rubidium Positron ...
Detailed Description
CCTA has become the preferred diagnostic modality for symptomatic patients with low to intermediate risk of CAD. Of the patients examined, CCTA exclude cardiovascular disease in 70-80% with an excelle...
Eligibility Criteria
Inclusion
- \-
- Patients with an indication for CCTA. Qualified patients who have signed a written informed consent form.
- \-
Exclusion
- Demography and co-existing cardiac morbidity specific: Age below 30 years, patients having a donor heart, a mechanic heart, or mechanical heart pump, suspicion acute coronary syndrome or previous revascularization.
- CCTA: Pregnant women, including women who are potentially pregnant or lactating, reduced kidney function, with an estimated glomerular filtration rate (eGFR) \< 40 mL/min or allergy to X-ray contrast medium.
- PET: contra-indication for adenosine (severe asthma, advanced atrioventricular block, or critical aorta stenosis).
Key Trial Info
Start Date :
January 5 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 5 2023
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04707859
Start Date
January 5 2021
End Date
January 5 2023
Last Update
January 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gødstrup Hospital
Herning, Denmark, 7400